Document is current
Any future updates will be listed below
-
Authors
Liu, Shiying
Gunzler, Douglas D.
Gunzler, Steven A.
Crawford, Dana C.
Briggs, Farren B. S.
-
Funding
Funding for this research was provided by:
The Michael J. Fox Foundation for Parkinson’s Research (MJFF-020155)
Clinical and Translational Science Collaborative of Cleveland (UL1TR002548)
National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health (UL1TR000439)
- License Information
-
More Information
Article History
Received: 26 January 2024
Accepted: 14 February 2025
First Online: 20 February 2025
Declarations
:
: The authors declare no competing interests.
: Participants in the Fox Insight provided informed consent and the study protocol was reviewed by the New England Institutional Review Board (IRB# 120160179, Legacy IRB# 14–236, Sponsor Protocol Number: 1, Study Title: Fox Insight)28. The current secondary data analysis was deemed non-human subjects by the IRB at Case Western Reserve University (#STUDY20210700). All methods were performed in accordance with the relevant guidelines and regulations.
